Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
Polytech Clermont Polytech Clermont
Higher Education, industry 4.0, edtech
Other
Fondation Héma-Québec Fondation Héma-Québec
edtech, Non-profit Organizations
Other

21 Oct 2024


Da Vinci Labs Da Vinci Labs
greentech, cleantech, Research Services
Other

23 Oct 2024


Pôle Emploi Pôle Emploi
Government Administration
Other

23 Sep 2024


United Nations Global Compact United Nations Global Compact
greentech, civictech, cleantech, International Affairs
Other

1 Oct 2024


Pacte mondial de l’ONU - Réseau France Pacte mondial de l’ONU - Réseau France
greentech, cleantech, Business Consulting and Services
Other

1 Oct 2024


Gefluc Arc Alpin : Les entreprises face au cancer Gefluc Arc Alpin : Les entreprises face au cancer
healthtech
Other

5 Oct 2024


inbiome inbiome
biotech, deeptech
Other

24 Sep 2024


Novus GmbH Novus GmbH
transporttech
Other

11 Oct 2024


JUJU'S Animations JUJU'S Animations
martech, foodtech, Food and Beverage Manufacturing
Other

18 Sep 2024


Radars
Loading...